Knowledge Center
Patent / Aug 04, 2022
Inhaled ivermectin
Source:
US 20220241307
The present invention contemplates the use of inhaled ivermectin for use in various viruses and parasitic infections (treatment and/or prophylaxis) that are present or manifest in the lungs or respiratory tract. Exemplary dosing, formulations, devices, and processing techniques are also disclosed herein.
Also in the Knowledge Center
Scientific Article
/ Jan 01, 1978
Esters of 16.alpha.- or 16.beta.-methyl-9.alpha.-chloro- or -fluorosteroids with high topical activity
Read more
Scientific Article
/ Jan 01, 1978
Alkali metal polymetaphosphate complexes of hydroxytetracycline.alpha.-6-deoxy-5-
Read more
Scientific Article